DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DBVT DBV Technologies S.A.

休市中 07-05 16:00:00 EDT

0.8388

+0.0928

+12.44%

盘后0.8380

-0.0008-0.10%

16:00 EDT

最高0.8388	最低0.7922	成交量9.63万
今开0.7922	昨收0.7460	日振幅6.25%
总市值8,089万	流通市值2,229万	总股本9,643万
成交额7.68万	换手率0.36%	流通股本2,658万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"DBVT","market":"US","secType":"STK","nameCN":"DBV Technologies S.A.","latestPrice":0.8388,"timestamp":1720209600000,"preClose":0.746,"halted":0,"volume":96347,"hourTrading":{"tag":"盘后","latestPrice":0.838,"preClose":0.8388,"latestTime":"16:00 EDT","volume":2,"amount":1.676,"timestamp":1720209602004},"delay":0,"floatShares":26576400,"shares":96434369,"eps":-0.415531,"marketStatus":"休市中","marketStatusCode":7,"change":0.0928,"latestTime":"07-05 16:00:00 EDT","open":0.7922,"high":0.8388,"low":0.7922,"amount":76837.156427,"amplitude":0.062466,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.415531,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1720425600000},"adr":1,"listingDate":1413950400000,"adjPreClose":0.746,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":0.7995,"preClose":0.76,"latestTime":"09:28 EDT","volume":40240,"amount":32157.798012,"timestamp":1720186105189},"postHourTrading":{"tag":"盘后","latestPrice":0.838,"preClose":0.8388,"latestTime":"16:00 EDT","volume":2,"amount":1.676,"timestamp":1720209602004},"volumeRatio":1.1186853565172694,"impliedVol":4.0465,"impliedVolPercentile":0.9957},"requestUrl":"/m/hq/s/DBVT/tweets","defaultTab":"tweets","newsList":[{"id":"2449260560","title":"Dbv Technologies盘中异动 大幅拉升6.19%报0.792美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449260560","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449260560?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:31","pubTimestamp":1720186292,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时31分，Dbv Technologies股票出现异动，股价大幅上涨6.19%。截至发稿，该股报0.792美元/股，成交量7.9929万股，换手率0.08%，振幅3.55%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.39%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213132957cb307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213132957cb307&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2448385224","title":"Dbv Technologies股价拉升10.12% 市值跌86.62万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448385224","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448385224?lang=zh_cn&edition=full","pubTime":"2024-07-04 00:44","pubTimestamp":1720025060,"startTime":"0","endTime":"0","summary":"北京时间2024年07月04日00时44分，Dbv Technologies股票出现异动，股价大幅拉升10.12%。截至发稿，该股报0.850美元/股，成交量259股，换手率0.00%，振幅5.76%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.70%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704004421941f38f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704004421941f38f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2448719606","title":"Dbv Technologies盘中异动 临近收盘股价大跌5.69%报0.772美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448719606","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448719606?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:57","pubTimestamp":1719950251,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时57分，Dbv Technologies股票出现波动，股价急速下挫5.69%。截至发稿，该股报0.772美元/股，成交量4.8746万股，换手率0.05%，振幅6.03%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.77%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703035731941f32f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703035731941f32f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139","DBVT"],"gpt_icon":0},{"id":"2448135079","title":"Dbv Technologies盘中异动 大幅拉升6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448135079","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448135079?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:38","pubTimestamp":1719841111,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时38分，Dbv Technologies股票出现异动，股价急速上涨6.24%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.36%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213832af900828&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213832af900828&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2446839646","title":"Dbv Technologies盘中异动 早盘大幅下跌6.00%报0.797美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446839646","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446839646?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:31","pubTimestamp":1719581499,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时31分，Dbv Technologies股票出现异动，股价急速下挫6.00%。截至发稿，该股报0.797美元/股，成交量5.4847万股，换手率0.06%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.03%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282131399f7138d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282131399f7138d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2446639901","title":"Dbv Technologies盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446639901","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446639901?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:03","pubTimestamp":1719410633,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时03分，Dbv Technologies股票出现波动，股价急速拉升5.08%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.24%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626220353af8f5884&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626220353af8f5884&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2443574679","title":"Dbv Technologies盘中异动 大幅下跌5.83%报0.970美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443574679","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443574679?lang=zh_cn&edition=full","pubTime":"2024-06-14 22:25","pubTimestamp":1718375136,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日22时25分，Dbv Technologies股票出现异动，股价快速下挫5.83%。截至发稿，该股报0.970美元/股，成交量7244股，换手率0.01%，振幅2.91%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.27%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614222536aef50a51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614222536aef50a51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","BK4139","DBVT"],"gpt_icon":0},{"id":"2442424028","title":"Dbv Technologies盘中异动 急速拉升9.39%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442424028","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442424028?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:32","pubTimestamp":1718026377,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时32分，Dbv Technologies股票出现波动，股价急速上涨9.39%。截至发稿，该股报1.10美元/股，成交量6160股，换手率0.01%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.49%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610213258941ed671&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610213258941ed671&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2441661370","title":"Dbv Technologies股价重挫17.09% 市值跌1546.32万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441661370","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441661370?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:31","pubTimestamp":1717767073,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日21时31分，Dbv Technologies股票出现异动，股价大幅下挫17.09%。截至发稿，该股报0.940美元/股，成交量25.5083万股，换手率0.27%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.05%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406072131139f24752f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406072131139f24752f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2441264297","title":"Dbv Technologies盘中异动 下午盘股价大跌5.16%报0.550美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441264297","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441264297?lang=zh_cn&edition=full","pubTime":"2024-06-07 02:54","pubTimestamp":1717700067,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日02时54分，Dbv Technologies股票出现波动，股价大幅下跌5.16%。截至发稿，该股报0.550美元/股，成交量5.9286万股，换手率0.03%，振幅3.83%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.40%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607025427941ed062&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607025427941ed062&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2441259450","title":"Dbv Technologies盘中异动 股价大跌11.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441259450","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441259450?lang=zh_cn&edition=full","pubTime":"2024-06-05 02:29","pubTimestamp":1717525795,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日02时29分，Dbv Technologies股票出现异动，股价快速下跌11.39%。截至发稿，该股报0.523美元/股，成交量22.5615万股，换手率0.12%，振幅4.08%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.04%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605022955941ec519&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605022955941ec519&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX","DBVT"],"gpt_icon":0},{"id":"2439990139","title":"Dbv Technologies盘中异动 股价大跌5.74%报0.540美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439990139","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439990139?lang=zh_cn&edition=full","pubTime":"2024-05-31 22:04","pubTimestamp":1717164246,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日22时04分，Dbv Technologies股票出现异动，股价大幅下跌5.74%。截至发稿，该股报0.540美元/股，成交量3.1208万股，换手率0.02%，振幅3.14%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.13%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531220406941eb840&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531220406941eb840&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2439449679","title":"Dbv Technologies盘中异动 下午盘大幅下挫6.35%报0.540美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439449679","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439449679?lang=zh_cn&edition=full","pubTime":"2024-05-31 02:28","pubTimestamp":1717093730,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日02时28分，Dbv Technologies股票出现异动，股价快速下跌6.35%。截至发稿，该股报0.540美元/股，成交量2.4839万股，换手率0.01%，振幅5.19%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.21%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531022850af8b2dce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531022850af8b2dce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2439630575","title":"Dbv Technologies盘中异动 股价大涨8.24%报0.643美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439630575","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439630575?lang=zh_cn&edition=full","pubTime":"2024-05-29 22:17","pubTimestamp":1716992266,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日22时17分，Dbv Technologies股票出现异动，股价大幅拉升8.24%。截至发稿，该股报0.643美元/股，成交量230股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.99%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052922174696810879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052922174696810879&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2435351673","title":"Dbv Technologies盘中异动 早盘急速上涨7.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435351673","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435351673?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:31","pubTimestamp":1715693513,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时31分，Dbv Technologies股票出现异动，股价快速拉升7.78%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.04%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421315479279e58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421315479279e58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2435373153","title":"Dbv Technologies盘中异动 早盘快速上涨9.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435373153","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435373153?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:33","pubTimestamp":1715607185,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时33分，Dbv Technologies股票出现异动，股价大幅上涨9.76%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.90%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321330587625fc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321330587625fc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2434685126","title":"Dbv Technologies盘中异动 早盘股价大涨5.17%报0.600美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434685126","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434685126?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:30","pubTimestamp":1715347828,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时30分，Dbv Technologies股票出现波动，股价急速拉升5.17%。截至发稿，该股报0.600美元/股，成交量917股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.97%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021302987e8718d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021302987e8718d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0},{"id":"2434988048","title":"Dbv Technologies盘中异动 股价大跌6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434988048","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434988048?lang=zh_cn&edition=full","pubTime":"2024-05-10 00:41","pubTimestamp":1715272866,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日00时41分，Dbv Technologies股票出现波动，股价大幅下跌6.10%。截至发稿，该股报0.652美元/股，成交量34.4296万股，换手率0.18%，振幅7.93%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.69%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510004107861ec270&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510004107861ec270&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2434771284","title":"Dbv Technologies盘中异动 股价大涨5.87%报0.720美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434771284","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434771284?lang=zh_cn&edition=full","pubTime":"2024-05-09 01:17","pubTimestamp":1715188672,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日01时17分，Dbv Technologies股票出现异动，股价大幅拉升5.87%。截至发稿，该股报0.720美元/股，成交量14.0971万股，换手率0.07%，振幅8.82%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.36%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050901175379268df7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050901175379268df7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"gpt_icon":0},{"id":"2429118016","title":"Dbv Technologies盘中异动 早盘股价大涨8.14%报0.715美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429118016","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429118016?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:51","pubTimestamp":1713880292,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时51分，Dbv Technologies股票出现异动，股价大幅拉升8.14%。截至发稿，该股报0.715美元/股，成交量2367股，换手率0.00%，振幅0.02%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.19%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232151337a54ee7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232151337a54ee7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dbvtechnologies.com","stockEarnings":[{"period":"1week","weight":0.0472},{"period":"1month","weight":-0.2768},{"period":"3month","weight":-0.4553},{"period":"6month","weight":-0.5158},{"period":"1year","weight":-0.7631},{"period":"ytd","weight":-0.5598}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0698},{"period":"6month","weight":0.1853},{"period":"1year","weight":0.2615},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"DBV Technologies S.A.是一家临床阶段专业生物制药公司，该公司专注于通过开发一个名为Viaskin的新的技术平台来改变免疫疗法领域。该公司的治疗方法是基于表皮免疫疗法（EPIT），该公司运用Viaskin新技术平台通过皮肤用专有的方法向免疫系统递送生物活性化合物。该公司是根据法兰西共和国法律注册成立于2002年3月29日。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.023953},{"month":2,"riseRate":0.5,"avgChangeRate":-0.00411},{"month":3,"riseRate":0.5,"avgChangeRate":0.002853},{"month":4,"riseRate":0.6,"avgChangeRate":0.072361},{"month":5,"riseRate":0.3,"avgChangeRate":-0.01824},{"month":6,"riseRate":0.3,"avgChangeRate":0.029895},{"month":7,"riseRate":0.5,"avgChangeRate":0.057319},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.044387},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.083505},{"month":10,"riseRate":0,"avgChangeRate":-0.203366},{"month":11,"riseRate":0.5,"avgChangeRate":0.029107},{"month":12,"riseRate":0.7,"avgChangeRate":-0.003851}],"exchange":"NASDAQ","name":"DBV Technologies S.A.","nameEN":"DBV Technologies SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"DBV Technologies S.A.,DBVT,DBV Technologies S.A.股票,DBV Technologies S.A.股票老虎,DBV Technologies S.A.股票老虎国际,DBV Technologies S.A.行情,DBV Technologies S.A.股票行情,DBV Technologies S.A.股价,DBV Technologies S.A.股市,DBV Technologies S.A.股票价格,DBV Technologies S.A.股票交易,DBV Technologies S.A.股票购买,DBV Technologies S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}